Products
-
Dodecyl Phosphocholine (DPC)
Dodecyl Phosphocholine (DPC) is a synthetic zwitterionic detergent widely used in membrane protein research and structural biology, especially in NMR spectroscopy and crystallography.
-
N-Acetylneuraminic Acid(Neu5Ac Sialic Acid)
N-Acetylneuraminic Acid (Neu5Ac), commonly known as sialic acid, is a naturally occurring monosaccharide involved in critical cellular and immune functions. It plays a key role in cell signaling, pathogen defense, and brain development.
-
Ergothioneine
Ergothioneine is a naturally occurring amino acid-derived antioxidant, studied for its powerful cytoprotective and anti-aging properties. It is synthesized by fungi and bacteria and accumulates in tissues exposed to oxidative stress.
-
NMN
Preclinical and early human studies suggest NMN may promote longevity, physical endurance, and cognitive performance.
API Features:
High purity ≥99%
Pharmaceutical-grade, suitable for oral or injectable formulations
Manufactured under GMP-like standards
NMN API is ideal for use in anti-aging supplements, metabolic therapies, and longevity research.
-
Glucagon
Glucagon is a natural peptide hormone used as an emergency treatment for severe hypoglycemia and studied for its role in metabolic regulation, weight loss, and digestive diagnostics.
-
Motixafortide
Motixafortide is a synthetic CXCR4 antagonist peptide developed to mobilize hematopoietic stem cells (HSCs) for autologous transplantation and is also being studied in oncology and immunotherapy.
-
Glepaglutide
Glepaglutide is a long-acting GLP-2 analog developed for the treatment of short bowel syndrome (SBS). It enhances intestinal absorption and growth, helping patients reduce dependence on parenteral nutrition.
-
Elamipretide
Elamipretide is a mitochondria-targeted tetrapeptide developed to treat diseases caused by mitochondrial dysfunction, including primary mitochondrial myopathy, Barth syndrome, and heart failure.
-
Donidalorsen
Donidalorsen API is an antisense oligonucleotide (ASO) under investigation for the treatment of hereditary angioedema (HAE) and related inflammatory conditions. It is studied in the context of RNA-targeted therapies, aiming to reduce the expression of plasma prekallikrein (KLKB1 mRNA). Researchers use Donidalorsen to explore gene silencing mechanisms, dose-dependent pharmacokinetics, and long-term control of bradykinin-mediated inflammation.
-
Fitusiran
Fitusiran API is a synthetic small interfering RNA (siRNA) investigated primarily in the field of hemophilia and coagulation disorders. It targets the antithrombin (AT or SERPINC1) gene in the liver to reduce antithrombin production. Researchers use Fitusiran to explore RNA interference (RNAi) mechanisms, liver-specific gene silencing, and novel therapeutic strategies for rebalancing coagulation in hemophilia A and B patients, with or without inhibitors.
-
Givosiran
Givosiran API is a synthetic small interfering RNA (siRNA) studied for the treatment of acute hepatic porphyria (AHP). It specifically targets the ALAS1 gene (aminolevulinic acid synthase 1), which is involved in the heme biosynthesis pathway. Researchers use Givosiran to investigate RNA interference (RNAi)-based therapies, liver-targeted gene silencing, and the modulation of metabolic pathways involved in porphyria and related genetic disorders.
-
Pegcetacoplan
Pegcetacoplan is a pegylated cyclic peptide that acts as a targeted C3 complement inhibitor, developed for the treatment of complement-mediated diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy (GA) in age-related macular degeneration.